{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:59:11Z","timestamp":1772722751740,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871190"],"award-info":[{"award-number":["31871190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171165"],"award-info":[{"award-number":["32171165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.intimp.2023.111158","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T23:51:41Z","timestamp":1699055501000},"page":"111158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"PA","title":["Pemetrexed ameliorates Con A-induced hepatic injury by restricting M1 macrophage activation"],"prefix":"10.1016","volume":"125","author":[{"given":"Zhaiyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyue","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8310-8257","authenticated-orcid":false,"given":"Guangrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2008.08.009","article-title":"The importance of immune dysfunction in determining outcome in acute liver failure","volume":"49","author":"Antoniades","year":"2008","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111158_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1499-3872(17)60014-6","article-title":"Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance","volume":"16","author":"Khan","year":"2017","journal-title":"Hepatob. Pancreatic Siseases Int.: HBPD INT"},{"issue":"2","key":"10.1016\/j.intimp.2023.111158_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0020","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.3390\/ijms15057711","article-title":"Importance of Kupffer cells in the development of acute liver injuries in mice","volume":"15","author":"Tsutsui","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2023.111158_b0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s13238-014-0069-5","article-title":"The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury","volume":"5","author":"Diao","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.intimp.2023.111158_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108411","article-title":"Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice","volume":"102","author":"Hao","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2023.111158_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim"},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/toxsci\/kft174","article-title":"Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells","volume":"136","author":"Fullerton","year":"2013","journal-title":"Toxicol. Sci.: Off. J. Soc. Toxicol."},{"key":"10.1016\/j.intimp.2023.111158_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2015.11.016","article-title":"Experimental models of hepatotoxicity related to acute liver failure","volume":"290","author":"Maes","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2023.111158_b0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11307-016-0976-3","article-title":"Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis","volume":"19","author":"Zheng","year":"2017","journal-title":"Mol. Imag. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111158_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1499-3872(11)60027-1","article-title":"Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice","volume":"10","author":"Chen","year":"2011","journal-title":"Hepatob. Pancreatic Siseases Int.: HBPD INT"},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2008.02.003","article-title":"Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis","volume":"251","author":"Hatano","year":"2008","journal-title":"Cell. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0075","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)64804-3","article-title":"Importance of Kupffer cells for T-cell-dependent liver injury in mice","volume":"157","author":"Sch\u00fcmann","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.111158_b0080","doi-asserted-by":"crossref","first-page":"35146","DOI":"10.1038\/srep35146","article-title":"Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis","volume":"6","author":"Amiya","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0085","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3892\/ijo.2013.1869","article-title":"A randomized phase II non-comparative study of pemetrexed-carboplatin and gemcitabine-vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients","volume":"42","author":"Amadori","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111158_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/07357907.2012.658938","article-title":"A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer","volume":"30","author":"Dittrich","year":"2012","journal-title":"Cancer Invest."},{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0095","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.3892\/or.2017.5951","article-title":"High pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase","volume":"38","author":"Kuo","year":"2017","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2023.111158_b0100","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1470-2045(16)30498-3","article-title":"Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study","volume":"17","author":"Langer","year":"2016","journal-title":"Lancet Oncol."},{"issue":"16","key":"10.1016\/j.intimp.2023.111158_b0105","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.7150\/jca.24948","article-title":"Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial","volume":"9","author":"Lim","year":"2018","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2023.111158_b0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/jm401574p","article-title":"Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth","volume":"57","author":"Pel\u00e0","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-010-1286-0","article-title":"Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer","volume":"126","author":"Robert","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"17","key":"10.1016\/j.intimp.2023.111158_b0120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1080\/14656566.2018.1536746","article-title":"The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer","volume":"19","author":"Rossi","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.intimp.2023.111158_b0125","first-page":"953","volume":"34","author":"Senan","year":"2016","journal-title":"Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111158_b0130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00280-013-2251-5","article-title":"Effects of pemetrexed, gefitinib, and their combination on human colorectal cancer cells","volume":"72","author":"Zhang","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.intimp.2023.111158_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153109","article-title":"Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3","volume":"66","author":"Ku","year":"2020","journal-title":"Phytomed.: Int. J. Phytother. Phytopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111158_b0140","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4014\/jmb.1501.01050","article-title":"H9 Inhibits Tumor Growth and Induces Apoptosis via Intrinsic and Extrinsic Signaling Pathway in Human Non-Small Cell Lung Cancer Xenografts","volume":"25","author":"Kim","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111158_b0145","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10753-023-01798-2","article-title":"Deletion of Cyclic GMP-AMP Synthase Aggravates Concanavalin A-Induced Acute Hepatic Injury by Facilitating Leukocyte Chemotaxis","volume":"46","author":"Liu","year":"2023","journal-title":"Inflammation"},{"issue":"11","key":"10.1016\/j.intimp.2023.111158_b0150","article-title":"Circadian control of ConA-induced acute liver injury and inflammatory response via Bmal1 regulation of Junb","volume":"5","author":"Liu","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.intimp.2023.111158_b0155","doi-asserted-by":"crossref","unstructured":"A.M. Curtis, C.T. Fagundes, G. Yang, E.M. Palsson-McDermott, P. Wochal, A.F. McGettrick, N.H. Foley, J.O. Early, L. Chen, H. Zhang, C. Xue, S.S. Geiger, K. Hokamp, M.P. Reilly, A.N. Coogan, E. Vigorito, G.A. FitzGerald, L.A. O'Neill, Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1, Proceedings of the National Academy of Sciences of the United States of America 112(23) (2015) 7231-6.","DOI":"10.1073\/pnas.1501327112"},{"key":"10.1016\/j.intimp.2023.111158_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.776879","article-title":"The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis","volume":"12","author":"Fuentelsaz-Romero","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.111158_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/516051","article-title":"Oxidative stress and mitogen-activated protein kinase pathways involved in cadmium-induced BRL 3A cell apoptosis","volume":"2013","author":"Yiran","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.intimp.2023.111158_b0170","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1002\/eji.201141783","article-title":"Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states","volume":"41","author":"Ivashkiv","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.111158_b0175","article-title":"CCN1 Promotes Inflammation by Inducing IL-6 Production via \u03b16\u03b21\/PI3K\/Akt\/NF-\u03baB Pathway in Autoimmune Hepatitis","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.111158_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119631","article-title":"Diallyl trisulfide protects against concanavalin A-induced acute liver injury in mice by inhibiting inflammation, oxidative stress and apoptosis","volume":"278","author":"Ding","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2023.111158_b0185","doi-asserted-by":"crossref","unstructured":"J. Liu, S. Luo, J. Yang, F. Ren, Y. Zhao, H. Luo, K. Ge, H. Zhang, The Protective Effect of Sheep Placental Extract on Concanavalin A-induced Liver Injury in Mice, Molecules (Basel, Switzerland) 24(1) (2018).","DOI":"10.3390\/molecules24010028"},{"issue":"11","key":"10.1016\/j.intimp.2023.111158_b0190","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1089\/ars.2009.2538","article-title":"Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease","volume":"11","author":"van der Veen","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2006-927397","article-title":"Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury","volume":"45","author":"Tiegs","year":"2007","journal-title":"Z. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111158_b0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111158_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2023.111158_b0210","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/2050640619872408","article-title":"Clinical management of autoimmune hepatitis","volume":"7","author":"Pape","year":"2019","journal-title":"United Eur. Gastroenterol J"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:08:52Z","timestamp":1761588532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923014844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":42,"alternative-id":["S1567576923014844"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111158","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemetrexed ameliorates Con A-induced hepatic injury by restricting M1 macrophage activation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111158"}}